Hematologic Malignancy: Clinical Trials

3 trials for Hematologic Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Terminated 3

Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Radiation Post-CAR T in Refractory Lymphoma
Radiotherapy - Hematologic Malignancy, Refractory Lymphoma
Not applicableTerminatedMassachusetts General Hospital32021-01-052025-09-24
Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
FLT PET/CT, MRI - Hematologic Malignancy
Not applicableTerminatedMasonic Cancer Center, University of Minnesota22014-01-012017-12-05
Influenza Vaccine Post Allogeneic Transplant
Influenza vaccine - Hematopoietic Stem Cell Transplant, Hematologic Malignancy
Not applicableTerminatedMasonic Cancer Center, University of Minnesota682010-09-012017-12-28

Narrower conditions

Hematologic Neoplasms (3)  ·  Lymphoma (2)  ·  Influenza, Human (1)  ·  Leukemia (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms, Plasma Cell (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms by Histologic Type (2)  ·  Bone Marrow Diseases (1)  ·  Infections (1)  ·  Orthomyxoviridae Infections (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Interventions

Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1)  ·  Influenza Vaccines (1)  ·  Radiotherapy (1)

Sponsors

Masonic Cancer Center, University of Minnesota (2)  ·  Massachusetts General Hospital (1)

Countries

United States (3)

Top investigators

Chirayu G Patel, MD, MPH (1)  ·  Michael Verneris, M.D. (1)  ·  Susanta K Hui, PhD (1)